web-based data capture system (Dacima Software Inc)
90
Structured Review
Dacima Software Inc
web-based data capture system
Web Based Data Capture System, supplied by Dacima Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/web-based+program/web+based+program/pmc12086309-328-8-7
Average 90 stars, based on 1 article reviews
Web Based Data Capture System, supplied by Dacima Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/web-based+program/web+based+program/pmc12086309-328-8-7
Average 90 stars, based on 1 article reviews
web-based data capture system - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Control:Article Title: Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012–2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research Network Article Snippet: Data were securely entered into the Article Title: A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial. Article Snippet: Background Recurrent ventricular tachycardia (VT) in patients with prior myocardial infarction is associated with adverse quality of life and clinical outcomes, despite the presence of implanted defibrillators (ICDs).. Suppression of recurrent VT can be accomplished with antiarrhythmic drug therapy or catheter ablation.. The Ventricular Tachycardia Antiarrhythmics or Ablation In Structural Heart Disease 2 (VANISH2) trial is designed to determine whether ablation is superior to antiarrhythmic drug therapy as first line therapy for patients with ischemic cardiomyopathy and VT. Methods The VANISH2 trial enrolls patients with prior myocardial infarction and VT (with one of: ≥1 ICD shock; ≥3 episodes treated with antitachycardia pacing (ATP) and symptoms; ≥5 episodes treated with ATP regardless of symptoms; ≥3 episodes within 24 hours; or sustained VT treated with electrical cardioversion or pharmacologic conversion). Article Title: Relationship Between Frailty and Respiratory Syncytial Virus Infection in Hospitalized Older Adults Article Snippet: The data were securely entered into the Article Title: Transcatheter mitral valve repair for inotrope dependent cardiogenic shock - Design and rationale of the CAPITAL MINOS trial. Article Snippet: Transcatheter mitral valve repair for inotrope dependent cardiogenic shock – Design and rationale of the CAPITAL MINOS trial Simon Parlow, MD a , b , ∗, Pietro Di Santo, MD a , b , c , ∗, Richard G. Jung, MD, PhD b , d , e , Neil Fam, MD, MSc f , Andrew Czarnecki, MD, MSc g , Eric Horlick, MDCM h , Omar Abdel-Razek, MD a , b , Vincent Chan, MD, MPH i , Mark Hynes, MD j , Donna Nicholson, MD, MSc j , Adam Dryden, MD j , Shannon M. Fernando, MD k , l , George A.. Wells, PhD c , m , Jordan Bernick, MSc m , Marino Labinaz, MD a , b , Rebecca Mathew, MD a , b , Trevor Simard, MD n , and Benjamin Hibbert, MD, PhD a , b , d Ontario, Canada Article Title: Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale. Article Snippet: Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale Pablo B. Nery, MD a , George A.. Wells, PhD a , b , Atul Verma, MD c , Jacqueline Joza, MD c , Girish M. Nair, MBBS, MSc a , George Veenhuyzen, MD d , Jason Andrade, MD e , Isabelle Nault, MD f , Jorge A. Wong, MD g , Markus Sikkel, MD h , Vidal Essebag, MD, PhD c , o , Laurent Macle, MD i , John Sapp, MD j , Jean-Francois Roux, MD k , Allan Skanes, MD l , Paul Angaran, MD m , Paul Novak, MD h , Damian Redfearn, MD n , Mehrdad Golian, MD a , Calum J. Redpath, MD a , Marcio Sturmer, MD o , and David Birnie, MD a Ottawa, Canada; Quebec, Canada; Nova Scotia, Canada Article Title: Systematic review of exercise therapy in the management of post-thrombotic syndrome Article Snippet: Search # Search Terms (MEDLINE and Cochrane) 1 Exercis* OR aerobic OR physical OR strength OR interval OR resistance OR isometric OR strength OR cardiovasc* OR aqua* OR Structured OR Supervi?e*) adj3 (exercis* OR activit* OR therap* OR program* OR train* OR rehab*):mp OR Physiotherapy.mp OR (Sport* or danc* or yoga or pilates or swim*).mp MESH: Exercise/ OR Sports/ OR Dancing/ OR Yoga/ OR Rehabilitation AND 2 Post-thrombotic syndrome OR postthrombotic disease OR post thrombotic syndrome OR postphlebitic syndrome OR venous stress disorder OR PTS MESH: Postthrombotic syndrome/ OR Postphlebitic syndrome/ Bias Author's judgement Support for judgement Random sequence generation (selection bias) Low risk Patients were randomized to exercise training or control via a Article Title: Systematic review of exercise therapy in the management of post-thrombotic syndrome Article Snippet: Random sequence generation (selection bias) Low risk Patients were randomized to exercise training or control via a Article Title: Systematic review of exercise therapy in the management of post-thrombotic syndrome Article Snippet: Allocation concealment (selection bias) Low risk Patients were randomized to exercise training or control via a Software:Article Title: Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012–2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research Network Article Snippet: Data were securely entered into the Article Title: A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial. Article Snippet: Background Recurrent ventricular tachycardia (VT) in patients with prior myocardial infarction is associated with adverse quality of life and clinical outcomes, despite the presence of implanted defibrillators (ICDs).. Suppression of recurrent VT can be accomplished with antiarrhythmic drug therapy or catheter ablation.. The Ventricular Tachycardia Antiarrhythmics or Ablation In Structural Heart Disease 2 (VANISH2) trial is designed to determine whether ablation is superior to antiarrhythmic drug therapy as first line therapy for patients with ischemic cardiomyopathy and VT. Methods The VANISH2 trial enrolls patients with prior myocardial infarction and VT (with one of: ≥1 ICD shock; ≥3 episodes treated with antitachycardia pacing (ATP) and symptoms; ≥5 episodes treated with ATP regardless of symptoms; ≥3 episodes within 24 hours; or sustained VT treated with electrical cardioversion or pharmacologic conversion). Article Title: Relationship Between Frailty and Respiratory Syncytial Virus Infection in Hospitalized Older Adults Article Snippet: The data were securely entered into the Article Title: Transcatheter mitral valve repair for inotrope dependent cardiogenic shock - Design and rationale of the CAPITAL MINOS trial. Article Snippet: Transcatheter mitral valve repair for inotrope dependent cardiogenic shock – Design and rationale of the CAPITAL MINOS trial Simon Parlow, MD a , b , ∗, Pietro Di Santo, MD a , b , c , ∗, Richard G. Jung, MD, PhD b , d , e , Neil Fam, MD, MSc f , Andrew Czarnecki, MD, MSc g , Eric Horlick, MDCM h , Omar Abdel-Razek, MD a , b , Vincent Chan, MD, MPH i , Mark Hynes, MD j , Donna Nicholson, MD, MSc j , Adam Dryden, MD j , Shannon M. Fernando, MD k , l , George A.. Wells, PhD c , m , Jordan Bernick, MSc m , Marino Labinaz, MD a , b , Rebecca Mathew, MD a , b , Trevor Simard, MD n , and Benjamin Hibbert, MD, PhD a , b , d Ontario, Canada Article Title: Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale. Article Snippet: Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale Pablo B. Nery, MD a , George A.. Wells, PhD a , b , Atul Verma, MD c , Jacqueline Joza, MD c , Girish M. Nair, MBBS, MSc a , George Veenhuyzen, MD d , Jason Andrade, MD e , Isabelle Nault, MD f , Jorge A. Wong, MD g , Markus Sikkel, MD h , Vidal Essebag, MD, PhD c , o , Laurent Macle, MD i , John Sapp, MD j , Jean-Francois Roux, MD k , Allan Skanes, MD l , Paul Angaran, MD m , Paul Novak, MD h , Damian Redfearn, MD n , Mehrdad Golian, MD a , Calum J. Redpath, MD a , Marcio Sturmer, MD o , and David Birnie, MD a Ottawa, Canada; Quebec, Canada; Nova Scotia, Canada Article Title: Systematic review of exercise therapy in the management of post-thrombotic syndrome Article Snippet: Search # Search Terms (MEDLINE and Cochrane) 1 Exercis* OR aerobic OR physical OR strength OR interval OR resistance OR isometric OR strength OR cardiovasc* OR aqua* OR Structured OR Supervi?e*) adj3 (exercis* OR activit* OR therap* OR program* OR train* OR rehab*):mp OR Physiotherapy.mp OR (Sport* or danc* or yoga or pilates or swim*).mp MESH: Exercise/ OR Sports/ OR Dancing/ OR Yoga/ OR Rehabilitation AND 2 Post-thrombotic syndrome OR postthrombotic disease OR post thrombotic syndrome OR postphlebitic syndrome OR venous stress disorder OR PTS MESH: Postthrombotic syndrome/ OR Postphlebitic syndrome/ Bias Author's judgement Support for judgement Random sequence generation (selection bias) Low risk Patients were randomized to exercise training or control via a Article Title: Systematic review of exercise therapy in the management of post-thrombotic syndrome Article Snippet: Random sequence generation (selection bias) Low risk Patients were randomized to exercise training or control via a Article Title: Systematic review of exercise therapy in the management of post-thrombotic syndrome Article Snippet: Allocation concealment (selection bias) Low risk Patients were randomized to exercise training or control via a Sequencing:Article Title: Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012–2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research Network Article Snippet: Data were securely entered into the Article Title: A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial. Article Snippet: Background Recurrent ventricular tachycardia (VT) in patients with prior myocardial infarction is associated with adverse quality of life and clinical outcomes, despite the presence of implanted defibrillators (ICDs).. Suppression of recurrent VT can be accomplished with antiarrhythmic drug therapy or catheter ablation.. The Ventricular Tachycardia Antiarrhythmics or Ablation In Structural Heart Disease 2 (VANISH2) trial is designed to determine whether ablation is superior to antiarrhythmic drug therapy as first line therapy for patients with ischemic cardiomyopathy and VT. Methods The VANISH2 trial enrolls patients with prior myocardial infarction and VT (with one of: ≥1 ICD shock; ≥3 episodes treated with antitachycardia pacing (ATP) and symptoms; ≥5 episodes treated with ATP regardless of symptoms; ≥3 episodes within 24 hours; or sustained VT treated with electrical cardioversion or pharmacologic conversion). Article Title: Relationship Between Frailty and Respiratory Syncytial Virus Infection in Hospitalized Older Adults Article Snippet: The data were securely entered into the Article Title: Transcatheter mitral valve repair for inotrope dependent cardiogenic shock - Design and rationale of the CAPITAL MINOS trial. Article Snippet: Transcatheter mitral valve repair for inotrope dependent cardiogenic shock – Design and rationale of the CAPITAL MINOS trial Simon Parlow, MD a , b , ∗, Pietro Di Santo, MD a , b , c , ∗, Richard G. Jung, MD, PhD b , d , e , Neil Fam, MD, MSc f , Andrew Czarnecki, MD, MSc g , Eric Horlick, MDCM h , Omar Abdel-Razek, MD a , b , Vincent Chan, MD, MPH i , Mark Hynes, MD j , Donna Nicholson, MD, MSc j , Adam Dryden, MD j , Shannon M. Fernando, MD k , l , George A.. Wells, PhD c , m , Jordan Bernick, MSc m , Marino Labinaz, MD a , b , Rebecca Mathew, MD a , b , Trevor Simard, MD n , and Benjamin Hibbert, MD, PhD a , b , d Ontario, Canada Article Title: Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale. Article Snippet: Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale Pablo B. Nery, MD a , George A.. Wells, PhD a , b , Atul Verma, MD c , Jacqueline Joza, MD c , Girish M. Nair, MBBS, MSc a , George Veenhuyzen, MD d , Jason Andrade, MD e , Isabelle Nault, MD f , Jorge A. Wong, MD g , Markus Sikkel, MD h , Vidal Essebag, MD, PhD c , o , Laurent Macle, MD i , John Sapp, MD j , Jean-Francois Roux, MD k , Allan Skanes, MD l , Paul Angaran, MD m , Paul Novak, MD h , Damian Redfearn, MD n , Mehrdad Golian, MD a , Calum J. Redpath, MD a , Marcio Sturmer, MD o , and David Birnie, MD a Ottawa, Canada; Quebec, Canada; Nova Scotia, Canada Article Title: Systematic review of exercise therapy in the management of post-thrombotic syndrome Article Snippet: Search # Search Terms (MEDLINE and Cochrane) 1 Exercis* OR aerobic OR physical OR strength OR interval OR resistance OR isometric OR strength OR cardiovasc* OR aqua* OR Structured OR Supervi?e*) adj3 (exercis* OR activit* OR therap* OR program* OR train* OR rehab*):mp OR Physiotherapy.mp OR (Sport* or danc* or yoga or pilates or swim*).mp MESH: Exercise/ OR Sports/ OR Dancing/ OR Yoga/ OR Rehabilitation AND 2 Post-thrombotic syndrome OR postthrombotic disease OR post thrombotic syndrome OR postphlebitic syndrome OR venous stress disorder OR PTS MESH: Postthrombotic syndrome/ OR Postphlebitic syndrome/ Bias Author's judgement Support for judgement Random sequence generation (selection bias) Low risk Patients were randomized to exercise training or control via a Article Title: Systematic review of exercise therapy in the management of post-thrombotic syndrome Article Snippet: Random sequence generation (selection bias) Low risk Patients were randomized to exercise training or control via a Article Title: Systematic review of exercise therapy in the management of post-thrombotic syndrome Article Snippet: Allocation concealment (selection bias) Low risk Patients were randomized to exercise training or control via a Selection:Article Title: Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012–2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research Network Article Snippet: Data were securely entered into the Article Title: A randomized clinical trial of catheter ablation and antiarrhythmic drug therapy for suppression of ventricular tachycardia in ischemic cardiomyopathy: The VANISH2 trial. Article Snippet: Background Recurrent ventricular tachycardia (VT) in patients with prior myocardial infarction is associated with adverse quality of life and clinical outcomes, despite the presence of implanted defibrillators (ICDs).. Suppression of recurrent VT can be accomplished with antiarrhythmic drug therapy or catheter ablation.. The Ventricular Tachycardia Antiarrhythmics or Ablation In Structural Heart Disease 2 (VANISH2) trial is designed to determine whether ablation is superior to antiarrhythmic drug therapy as first line therapy for patients with ischemic cardiomyopathy and VT. Methods The VANISH2 trial enrolls patients with prior myocardial infarction and VT (with one of: ≥1 ICD shock; ≥3 episodes treated with antitachycardia pacing (ATP) and symptoms; ≥5 episodes treated with ATP regardless of symptoms; ≥3 episodes within 24 hours; or sustained VT treated with electrical cardioversion or pharmacologic conversion). Article Title: Relationship Between Frailty and Respiratory Syncytial Virus Infection in Hospitalized Older Adults Article Snippet: The data were securely entered into the Article Title: Transcatheter mitral valve repair for inotrope dependent cardiogenic shock - Design and rationale of the CAPITAL MINOS trial. Article Snippet: Transcatheter mitral valve repair for inotrope dependent cardiogenic shock – Design and rationale of the CAPITAL MINOS trial Simon Parlow, MD a , b , ∗, Pietro Di Santo, MD a , b , c , ∗, Richard G. Jung, MD, PhD b , d , e , Neil Fam, MD, MSc f , Andrew Czarnecki, MD, MSc g , Eric Horlick, MDCM h , Omar Abdel-Razek, MD a , b , Vincent Chan, MD, MPH i , Mark Hynes, MD j , Donna Nicholson, MD, MSc j , Adam Dryden, MD j , Shannon M. Fernando, MD k , l , George A.. Wells, PhD c , m , Jordan Bernick, MSc m , Marino Labinaz, MD a , b , Rebecca Mathew, MD a , b , Trevor Simard, MD n , and Benjamin Hibbert, MD, PhD a , b , d Ontario, Canada Article Title: Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale. Article Snippet: Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale Pablo B. Nery, MD a , George A.. Wells, PhD a , b , Atul Verma, MD c , Jacqueline Joza, MD c , Girish M. Nair, MBBS, MSc a , George Veenhuyzen, MD d , Jason Andrade, MD e , Isabelle Nault, MD f , Jorge A. Wong, MD g , Markus Sikkel, MD h , Vidal Essebag, MD, PhD c , o , Laurent Macle, MD i , John Sapp, MD j , Jean-Francois Roux, MD k , Allan Skanes, MD l , Paul Angaran, MD m , Paul Novak, MD h , Damian Redfearn, MD n , Mehrdad Golian, MD a , Calum J. Redpath, MD a , Marcio Sturmer, MD o , and David Birnie, MD a Ottawa, Canada; Quebec, Canada; Nova Scotia, Canada Article Title: Systematic review of exercise therapy in the management of post-thrombotic syndrome Article Snippet: Search # Search Terms (MEDLINE and Cochrane) 1 Exercis* OR aerobic OR physical OR strength OR interval OR resistance OR isometric OR strength OR cardiovasc* OR aqua* OR Structured OR Supervi?e*) adj3 (exercis* OR activit* OR therap* OR program* OR train* OR rehab*):mp OR Physiotherapy.mp OR (Sport* or danc* or yoga or pilates or swim*).mp MESH: Exercise/ OR Sports/ OR Dancing/ OR Yoga/ OR Rehabilitation AND 2 Post-thrombotic syndrome OR postthrombotic disease OR post thrombotic syndrome OR postphlebitic syndrome OR venous stress disorder OR PTS MESH: Postthrombotic syndrome/ OR Postphlebitic syndrome/ Bias Author's judgement Support for judgement Random sequence generation (selection bias) Low risk Patients were randomized to exercise training or control via a Article Title: Systematic review of exercise therapy in the management of post-thrombotic syndrome Article Snippet: Random sequence generation (selection bias) Low risk Patients were randomized to exercise training or control via a Article Title: Systematic review of exercise therapy in the management of post-thrombotic syndrome Article Snippet: Allocation concealment (selection bias) Low risk Patients were randomized to exercise training or control via a |